Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data

Genes Chromosomes and Cancer

Volumn 51, Issue 7, 2012, Pages 696-706

  Kuijjer, Marieke L ^a   Rydbeck, Halfdan ^b   Kresse, Stine H ^c   Buddingh, Emilie P ^a   Lid, Ana B ^b,c   Roelofs, Helene ^a   Bürger, Horst ^d   Myklebost, Ola ^b,c   Hogendoorn, Pancras C W ^a   Meza Zepeda, Leonardo A ^b,c   Cleton Jansen, Anne Marie ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; MINICHROMOSOME MAINTENANCE PROTEIN 4;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE IDENTIFICATION; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; MALE; MESENCHYMAL STEM CELL; OSTEOBLAST; OSTEOSARCOMA; PRIORITY JOURNAL;

BIOPSY; BONE NEOPLASMS; CLUSTER ANALYSIS; DISEASE PROGRESSION; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC INSTABILITY; HUMANS; MALE; MESENCHYMAL STEM CELLS; OSTEOBLASTS; OSTEOSARCOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 84860662550     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.21956     Document Type: Article

References (39)

1. Aguilera A, Gomez-Gonzalez B. 2008. Genome instability: A mechanistic view of its causes and consequences. Nat Rev Genet 9: 204-217.
2. Alexa A, Rahnenfuhrer J, Lengauer T. 2006. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics 22: 1600-1607.
3. Alison MR, Hunt T, Forbes SJ. 2002. Minichromosome maintenance (MCM) proteins may be pre-cancer markers. Gut 50: 290-291.
4. Atiye J, Wolf M, Kaur S, Monni O, Bohling T, Kivioja A, Tas E, Serra M, Tarkkanen M, Knuutila S. 2005. Gene amplifications in osteosarcoma-CGH microarray analysis. Genes Chrom Cancer 42: 158-163.
5. Aylon Y, Michael D, Shmueli A, Yabuta N, Nojima H, Oren M. 2006. A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev 20: 2687-2700.
6. Aylon Y, Yabuta N, Besserglick H, Buganim Y, Rotter V, Nojima H, Oren M. 2009. Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation. Oncogene 28: 4469-4479.
7. Bicciato S, Spinelli R, Zampieri M, Mangano E, Ferrari F, Beltrame L, Cifola I, Peano C, Solari A, Battaglia C. 2009. A computational procedure to identify significant overlap of differentially expressed and genomic imbalanced regions in cancer datasets. Nucleic Acids Res 37: 5057-5070.
8. Buddingh EP, Kuijjer ML, Duim RA, Burger H, Agelopoulos K, Myklebost O, Serra M, Mertens F, Hogendoorn PCW, Lankester AC, Cleton-Jansen AM. 2011. Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: A rationale for treatment with macrophage-activating agents. Clin Cancer Res 17: 2110-2119.
9. Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z. 2006. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 38: 1043-1048.
10. Cleton-Jansen AM, Buerger H, Hogendoom PCW. 2005. Central high-grade osteosarcoma of bone: Diagnostic and genetic considerations. Curr Diagn Pathol 11: 390-399.
11. Cleton-Jansen AM, Anninga JK, Briaire-de Bruijn I, Romeo S, Oosting J, Egeler RM, Gelderblom H, Taminiau AH, Hogendoorn PCW. 2009. Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways. Br J Cancer 101: 2064.
12. Fousteri M, Mullenders LH. 2008. Transcription-coupled nucleotide excision repair in mammalian cells: Molecular mechanisms and biological effects. Cell Res 18: 73-84.
13. Freeman A, Morris LS, Mills AD, Stoeber K, Laskey RA, Williams GH, Coleman N. 1999. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res 5: 2121-2132.
14. Ganem NJ, Pellman D. 2007a. Limiting the proliferation of polyploid cells. Cell 131: 437-440.
15. Ganem NJ, Storchova Z, Pellman D. 2007b. Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 17: 157-162.
16. Kresse SH, Szuhai K, Barragan-Polania AH, Rydbeck H, Cleton-Jansen AM, Myklebost O, Meza-Zepeda LA. 2010. Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours. BMC Res Notes 3: 223.
17. Kuijjer ML, Namlos HM, Hauben EI, Machado I, Kresse SH, Serra M, Llombart-Bosch A, Hogendoorn PC, Meza-Zepeda LA, Myklebost O, Cleton-Jansen AM. 2011. mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts. BMC Med Genomics 4: 66.
18. Lee H, Kong SW, Park PJ. 2008. Integrative analysis reveals the direct and indirect interactions between DNA copy number aberrations and gene expression changes. Bioinformatics 24: 889-896.
19. Lee YH, Tokunaga T, Oshika Y, Suto R, Yanagisawa K, Tomisawa M, Fukuda H, Nakano H, Abe S, Tateishi A, Kijima H, Yamazaki H, Tamaoki N, Ueyama Y, Nakamura M. 1999. Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer 35: 1089-1093.
20. Louhimo R, Hautaniemi S. 2011. CNAmet: An R package for integrating copy number, methylation and expression data. Bioinformatics 27: 887-888.
21. Ma T, Shi T, Huang J, Wu L, Hu F, He P, Deng W, Gao P, Zhang Y, Song Q, Ma D, Qiu X. 2008. DCUN1D3, a novel UVC-responsive gene that is involved in cell cycle progression and cell growth. Cancer Sci 99: 2128-2135.
22. Majid S, Dar AA, Saini S, Chen Y, Shahryari V, Liu J, Zaman MS, Hirata H, Yamamura S, Ueno K, Tanaka Y, Dahiya R. 2010. Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer Res 70: 2809-2818.
23. Man TK, Lu XY, Jaeweon K, Perlaky L, Harris CP, Shah S, Ladanyi M, Gorlick R, Lau CC, Rao PH. 2004. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer 4: 45.
24. Mohseny AB, Szuhai K, Romeo S, Buddingh EP, Briaire-de Bruijn I, de Jong D, van Pel M, Cleton-Jansen AM, Hogendoorn PCW. 2009. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2. J Pathol 219: 294-305.
25. Mohseny AB, Hogendoorn PC. 2011. Concise review: Mesenchymal tumors: When stem cells go mad. Stem Cells 29: 397-403.
26. Ottaviano L, Schaefer KL, Gajewski M, Huckenbeck W, Baldus S, Rogel U, Mackintosh C, de Alava E, Myklebost O, Kresse SH, Meza-Zepeda LA, Serra M, Cleton-Jansen AM, Hogendoorn PCW, Buerger H, Aigner T, Gabbert HE, Poremba C. 2010. Molecular characterization of commonly used cell lines for bone tumor research: A Trans-European EuroBoNet Effort. Genes Chrom Cancer 49: 40-51.
27. Pansuriya TC, Oosting J, Krenacs T, Taminiau AH, Verdegaal SH, Sangiorgi L, Sciot R, Hogendoorn PC, Szuhai K, Bovee JV. 2011. Genome-wide analysis of Ollier disease: Is it all in the genes? Orphanet J Rare Dis 6: 2.
28. R Development Core Team. 2005. R: A Language and Environment for Statistical Computing, Reference Index Version 2.10.0. Vienna, Austria: R Foundation for Statistical Computing.
29. Raymond AK, Ayala AG, Knuutila S. 2002. Conventional osteosarcoma. In: Fletcher CDM, Unni KK, Mertens F, editors. World Health Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, pp 264-270.
30. Salari K, Tibshirani R, Pollack JR. 2010. DR-Integrator: A new analytic tool for integrating DNA copy number and gene expression data. Bioinformatics 26: 414-416.
31. Smyth GK. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article 3.
32. Soneson C, Lilljebjorn H, Fioretos T, Fontes M. 2010. Integrative analysis of gene expression and copy number alterations using canonical correlation analysis. BMC Bioinformatics 11: 191.
33. Squire JA, Pei J, Marrano P, Beheshti B, Bayani J, Lim G, Moldovan L, Zielenska M. 2003. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays. Genes Chrom Cancer 38: 215-225.
34. Suzuki R, Shimodaira H. 2006. Pvclust: An R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 22: 1540-1542.
35. UniProt Consortium. 2011. Ongoing and future developments at the Universal Protein Resource. Nucleic Acids Res 39: D214-D219.
36. Vaske CJ, Benz SC, Sanborn JZ, Earl D, Szeto C, Zhu J, Haussler D, Stuart JM. 2010. Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics 26: i237-i245.
37. Visser S, Yang X. 2010. LATS tumor suppressor: A new governor of cellular homeostasis. Cell Cycle 9: 3892-3903.
38. Yen CC, Chen WM, Chen TH, Chen WY, Chen PC, Chiou HJ, Hung GY, Wu HT, Wei CJ, Shiau CY, Wu YC, Chao TC, Tzeng CH, Chen PM, Lin CH, Chen YJ, Fletcher JA. 2009. Identification of chromosomal aberrations associated with disease progression and a novel 3q13.31 deletion involving LSAMP gene in osteosarcoma. Int J Oncol 35: 775-788.
39. Zhou X, Munger K. 2010. Clld7, a candidate tumor suppressor on chromosome 13q14, regulates pathways of DNA damage/repair and apoptosis. Cancer Res 70: 9434-9443.